We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 10,000 results
  1. Branchioma with a nested/organoid morphology: molecular profiling of a distinctive potentially misleading variant and reappraisal of potential relationship to CD34-positive/Rb1-deficient tumors of the neck

    Branchioma (previously called ectopic hamartomatous thymoma, branchial anlage mixed tumor, or thymic anlage tumor) is a rare lower neck lesion with...

    Martina Baněčková, Michael Michal, ... Abbas Agaimy in Virchows Archiv
    Article Open access 04 July 2023
  2. Clinical significance of CD34+CD117dim/CD34+CD117bri myeloblast-associated gene expression in t(8;21) acute myeloid leukemia

    t(8;21)(q22;q22) acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy with a high relapse rate in China. Two leukemic...

    Xue** Li, Yuting Dai, ... Lu Jiang in Frontiers of Medicine
    Article 23 March 2021
  3. Circulating CD34+ cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice

    Introduction

    Primary myelofibrosis (PMF) is a clonal stem cell disorder characterized by myeloid dominant hematopoiesis and dysregulated proliferation...

    Noriyuki Saito, Takuji Yamauchi, ... Fumihiko Ishikawa in International Journal of Hematology
    Article 13 November 2021
  4. Does the Inclusion of CD34+ B-cell Progenitors (Hematogones) in Stem Cell Enumeration of Apheresis Product Using ISHAGE Protocol Affect the Final Harvest dose Adequacy and the Outcome of Transplantation? A Single Institution Experience from Southern India

    Purpose

    Hematogones have similar antigenic and light scatter properties when compared to CD34+ hematopoietic stem cells (HSC) but they form a separate...

    Naadia Fatima Nadeem, Prabhu Manivannan, ... Abhishekh Gowda in Indian Journal of Hematology and Blood Transfusion
    Article 03 January 2023
  5. Negative value of CD10/CD34 immunophenotype in pediatric leukemia and development of a related cell line model for investigating drug resistance

    Purpose

    Appropriate sub-classification of leukemia according to the immunophenotypic characteristics of the malignant cells may improve therapeutic...

    N. Aberuyi, S. Rahgozar in Clinical and Translational Oncology
    Article 05 January 2022
  6. Integrated single-cell transcriptome analysis of CD34 + enriched leukemic stem cells revealed intra- and inter-patient transcriptional heterogeneity in pediatric acute myeloid leukemia

    To gain insights into the idiosyncrasies of CD34 + enriched leukemic stem cells, we investigated the nature and extent of transcriptional...

    Deepshi Thakral, Vivek Kumar Singh, ... Rachna Seth in Annals of Hematology
    Article 17 December 2022
  7. Analysis of vascularization in thyroid gland nodes with superb microvascular imaging (SMI) and CD34 expression histology: a pilot study

    Background

    The Doppler sonography technique known as "superb microvascular imaging" (SMI) is advancing sonographic micro vascularization imaging in...

    Thomas Studeny, Wolfgang Kratzer, ... Andreas Hillenbrand in BMC Medical Imaging
    Article Open access 30 October 2021
  8. Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients

    Background

    Diabetes-induced trained immunity contributes to the development of atherosclerosis and its complications. This study aimed to investigate...

    Maria Cristina Vinci, Sarah Costantino, ... Giulio Pompilio in Cardiovascular Diabetology
    Article Open access 29 March 2024
  9. Lack of CD34 delays bacterial endotoxin-induced lung inflammation

    Background

    CD34, a pan-selectin binding protein when glycosylated, has been shown to be involved in leukocyte migration to the site of inflammation....

    Gurpreet K. Aulakh, Sushmita Maltare, Baljit Singh in Respiratory Research
    Article Open access 25 February 2021
  10. The impact of CD33/CD34 ratio in the prognosis of myelodysplastic syndrome treated with azacitidine for first-line therapy

    Purpose

    Azacitidine (AZA), a hypomethylating agent, is the standard treatment for patients with myelodysplastic syndromes (MDS). However, responses...

    Satoko Oka, Kazuo Ono in Journal of Hematopathology
    Article 15 July 2021
  11. Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

    The optimal CD34 + cell dose in the setting of RIC allo-HCT for myelofibrosis (MF) remains unknown. We retrospectively analyzed 657 patients with...

    Tomasz Czerw, Simona Iacobelli, ... Ibrahim Yakoub-Agha in Bone Marrow Transplantation
    Article 01 December 2021
  12. Overlap** morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor

    Superficial CD34-positive fibroblastic tumor (SCD34FT) is a recently recognized soft tissue tumor that is considered to be of borderline malignancy....

    Florian Puls, Jodi M. Carter, ... Fredrik Mertens in Modern Pathology
    Article 30 December 2021
  13. Early and late stage MPN patients show distinct gene expression profiles in CD34+ cells

    Myeloproliferative neoplasms (MPN), comprising essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF), are...

    Julian Baumeister, Tiago Maié, ... Deniz Gezer in Annals of Hematology
    Article Open access 14 August 2021
  14. Associations between handgrip strength and hypertension in relation to circulating CD34-positive cell levels among Japanese older men: a cross-sectional study

    Background

    A positive association between handgrip strength and blood pressure has been reported. Since these factors are linked to the condition of...

    Yuji Shimizu, Shin-Ya Kawashiri, ... Takahiro Maeda in Environmental Health and Preventive Medicine
    Article Open access 04 June 2021
  15. Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide

    Higher infused total nucleated cell dose (TNC) in allogeneic bone marrow transplant (BMT) with post-transplant cyclophosphamide (PTCy) is associated...

    Hany Elmariah, Syeda Mahrukh Hussnain Naqvi, ... Nelli Bejanyan in Bone Marrow Transplantation
    Article 03 March 2021
Did you find what you were looking for? Share feedback.